Pro company pages include CSV downloads for statements, ratios, chart data, and transcript indexes.
NASDAQ · US
Ion implantation equipment supplier for semiconductor device manufacturing.
Implant equipment exposure to logic, power, and memory capacity supporting AI infrastructure.
Price
$187.53
Change
+12.09 (+6.89%)
Market cap
$5.8B
52w range
$65–$194
Exchange
NASDAQ
Country
US
Jason's Chips
Subscribe or sign in with your Substack email for charts, exports, estimates, transcripts, filings, earnings, and news.
Daily close for Axcelis Technologies, Inc.
Download statements, ratios, chart data, and transcript indexes.
Revenue, gross profit, R&D, operating income, EBITDA, net income, and EPS.
Cash, receivables, inventory, PP&E, assets, debt, liabilities, and equity.
Operating cash flow, capital expenditures, and free cash flow.
Enterprise value, valuation multiples, returns, yields, and cash conversion.
Margins, liquidity ratios, valuation ratios, leverage, and per-share metrics.
Five years of daily close and volume data powering the company chart.
Available earnings-call transcript dates by fiscal year and quarter.
Strong buy
0
Buy
8
Hold
3
Sell
1
Strong sell
0
| Period | Revenue avg | Revenue range | EPS avg | EPS range | EBITDA avg | EBIT avg | Net income avg | SG&A avg | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| 2026-12-31 | $843.9M | $842.1M - $845.7M | $3.83 | $3.69 - $4.01 | $193.9M | $180.9M | $122.1M | $116.3M | 3 rev / 3 EPS |
| 2027-12-31 | $925.2M | $901.7M - $948.7M | $4.85 | $4.45 - $5.08 | $212.6M | $198.3M | $151.0M | $127.5M | 4 rev / 3 EPS |
| 2028-12-31 | $1.03B | $1.01B - $1.06B | $5.01 | $4.87 - $5.20 | $236.7M | $220.8M | $158.7M | $141.9M | 1 rev / 1 EPS |
| Period | Revenue avg | Revenue range | EPS avg | EPS range | EBITDA avg | EBIT avg | Net income avg | SG&A avg | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $205.0M | $204.9M - $205.1M | $0.89 | $0.89 - $0.90 | $47.1M | $43.9M | $27.7M | $28.3M | 3 rev / 3 EPS |
| 2026-09-30 | $214.8M | $214.6M - $215.0M | $1.04 | $0.99 - $1.09 | $49.3M | $46.0M | $32.2M | $29.6M | 3 rev / 2 EPS |
| 2026-12-31 | $225.1M | $224.6M - $225.4M | $1.18 | $1.18 - $1.18 | $51.7M | $48.3M | $36.6M | $31.0M | 2 rev / 1 EPS |
| 2027-03-31 | $222.6M | $222.0M - $222.8M | $1.09 | $1.09 - $1.09 | $51.1M | $47.7M | $33.8M | $30.7M | 1 rev / 1 EPS |
| 2027-06-30 | $221.0M | $220.5M - $221.3M | $1.12 | $1.12 - $1.12 | $50.8M | $47.4M | $34.7M | $30.5M | 2 rev / 1 EPS |
| 2027-09-30 | $226.5M | $226.0M - $226.8M | $1.19 | $1.19 - $1.19 | $52.0M | $48.6M | $36.9M | $31.2M | 2 rev / 1 EPS |
| 2027-12-31 | $231.6M | $231.0M - $231.9M | $1.26 | $1.26 - $1.27 | $53.2M | $49.6M | $39.1M | $31.9M | 1 rev / 1 EPS |
| Window | Targets | Average target |
|---|---|---|
| Last month | 0 | $0.00 |
| Last quarter | 0 | $0.00 |
| Last year | 1 | $110.00 |
| All time | 5 | $117.80 |
Sources: TheFly, Benzinga
| Date | Firm | Action | Previous | New |
|---|---|---|---|---|
| 2026-02-18 | B. Riley Securities | Maintain | Neutral | Neutral |
| 2026-01-21 | B. Riley Securities | Maintain | Neutral | Neutral |
| 2026-01-13 | B of A Securities | Maintain | Underperform | Underperform |
| 2025-11-05 | B. Riley Securities | Maintain | Neutral | Neutral |
| 2025-10-13 | B of A Securities | Downgrade | Neutral | Underperform |
| 2025-10-02 | DA Davidson | Maintain | Buy | Buy |
| 2025-10-02 | Benchmark | Upgrade | Hold | Buy |
| 2025-08-06 | DA Davidson | Maintain | Buy | Buy |
| Date | Strong buy | Buy | Hold | Sell | Strong sell |
|---|---|---|---|---|---|
| 2026-06-01 | 0 | 2 | 2 | 0 | 1 |
| 2026-05-01 | 0 | 2 | 2 | 0 | 1 |
| 2026-04-01 | 0 | 2 | 3 | 0 | 1 |
| 2026-03-01 | 0 | 1 | 3 | 0 | 1 |
| 2026-02-01 | 0 | 2 | 3 | 0 | 1 |
| 2026-01-01 | 0 | 3 | 3 | 0 | 1 |
| 2025-12-01 | 0 | 3 | 3 | 0 | 1 |
| 2025-11-01 | 0 | 3 | 3 | 0 | 1 |
| Period | Revenue | Gross profit | Gross margin | R&D | Operating income | EBITDA | Net income | EPS |
|---|---|---|---|---|---|---|---|---|
| FY 2025 | $839.0M | $376.8M | 44.9% | $109.0M | $119.3M | $161.2M | $120.2M | $3.81 |
| FY 2024 | $1.02B | $454.7M | 44.7% | $105.5M | $210.8M | $251.5M | $201.0M | $6.17 |
| FY 2023 | $1.13B | $491.3M | 43.5% | $96.9M | $265.8M | $297.0M | $246.3M | $7.52 |
| FY 2022 | $920.0M | $401.8M | 43.7% | $78.4M | $212.4M | $222.1M | $183.1M | $5.54 |
| FY 2021 | $662.4M | $286.4M | 43.2% | $65.4M | $127.3M | $136.1M | $98.7M | $2.94 |
| FY 2020 | $474.6M | $198.6M | 41.8% | $61.8M | $58.0M | $71.0M | $50.0M | $1.50 |
| FY 2019 | $343.0M | $144.2M | 42.0% | $53.9M | $24.2M | $34.0M | $17.0M | $0.52 |
| FY 2018 | $442.6M | $179.6M | 40.6% | $51.9M | $60.0M | $65.6M | $45.9M | $1.35 |
| FY 2017 | $410.6M | $150.2M | 36.6% | $43.1M | $47.8M | $54.0M | $127.0M | $4.11 |
| FY 2016 | $267.0M | $99.6M | 37.3% | $34.4M | $16.6M | $20.4M | $11.0M | $0.38 |
| FY 2015 | $301.5M | $101.7M | 33.7% | $32.6M | $20.7M | $25.6M | $14.7M | $0.52 |
| FY 2014 | $203.1M | $70.2M | 34.6% | $33.5M | -$10.7M | -$4.5M | -$11.3M | $-0.40 |
| Period | Operating cash flow | Capex | Free cash flow |
|---|---|---|---|
| FY 2025 | $118.3M | $11.3M | $107.0M |
| FY 2024 | $140.8M | $12.2M | $128.6M |
| FY 2023 | $156.9M | $20.7M | $136.2M |
| FY 2022 | $215.6M | $10.7M | $204.9M |
| FY 2021 | $150.2M | $8.7M | $141.5M |
| FY 2020 | $69.7M | $7.4M | $62.3M |
| FY 2019 | -$13.6M | $12.0M | -$25.6M |
| FY 2018 | $47.0M | $4.7M | $42.3M |
| FY 2017 | $56.3M | $7.3M | $49.0M |
| FY 2016 | -$8.8M | $2.5M | -$11.3M |
| FY 2015 | $18.3M | $1.8M | $16.4M |
| FY 2014 | -$16.0M | $1.0M | -$17.1M |
| Period | Cash + ST inv. | Receivables | Inventory | PP&E | Assets | Debt | Net debt | Liabilities | Equity |
|---|---|---|---|---|---|---|---|---|---|
| FY 2025 | $374.3M | $168.5M | $329.0M | $99.2M | $1.36B | $42.3M | -$103.1M | $326.7M | $1.03B |
| FY 2024 | $571.3M | $203.1M | $282.2M | $98.8M | $1.35B | $43.7M | -$79.8M | $336.0M | $1.01B |
| FY 2023 | $506.1M | $218.0M | $306.5M | $101.3M | $1.28B | $45.2M | -$122.1M | $417.1M | $864.9M |
| FY 2022 | $432.2M | $169.8M | $242.4M | $69.8M | $1.01B | $46.4M | -$139.2M | $346.4M | $667.3M |
| FY 2021 | $294.9M | $104.4M | $195.0M | $63.5M | $753.2M | $47.4M | -$247.5M | $214.3M | $539.0M |
| FY 2020 | $203.5M | $86.9M | $161.1M | $54.9M | $624.6M | $48.1M | -$155.3M | $143.0M | $481.6M |
| FY 2019 | $139.9M | $83.8M | $140.4M | $53.1M | $548.1M | $48.5M | -$91.3M | $128.7M | $419.4M |
| FY 2018 | $178.0M | $78.7M | $129.0M | $41.1M | $548.4M | $47.8M | -$130.2M | $140.1M | $408.3M |
| FY 2017 | $133.4M | $75.3M | $120.5M | $36.2M | $488.2M | $47.7M | -$85.7M | $134.6M | $353.6M |
| FY 2016 | $70.8M | $50.6M | $113.9M | $30.8M | $302.2M | $47.6M | -$23.2M | $100.8M | $201.5M |
| FY 2015 | $78.9M | $36.9M | $115.9M | $30.0M | $288.3M | $47.6M | -$31.3M | $98.0M | $190.3M |
| FY 2014 | $30.8M | $42.8M | $104.1M | $30.5M | $227.7M | $14.5M | -$16.2M | $59.3M | $168.4M |
| Period | Gross margin | Op margin | Net margin | Current | Quick | ROE | ROIC | EV / sales | EV / EBITDA | FCF yield | R&D / rev. | Cash cycle |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FY 2025 | 44.9% | 14.2% | 14.3% | 4.8x | 3.1x | 11.6% | 8.9% | 2.9x | 15.1x | 4.2% | 13.0% | 300d |
| FY 2024 | 44.7% | 20.7% | 19.7% | 5.4x | 4.1x | 19.8% | 16.1% | 2.2x | 8.7x | 5.7% | 10.4% | 225d |
| FY 2023 | 43.5% | 23.5% | 21.8% | 3.8x | 2.7x | 28.5% | 23.5% | 3.6x | 13.9x | 3.2% | 8.6% | 214d |
| FY 2022 | 43.7% | 23.1% | 19.9% | 3.5x | 2.6x | 27.4% | 24.7% | 2.7x | 11.2x | 7.8% | 8.5% | 194d |
| FY 2021 | 43.2% | 19.2% | 14.9% | 4.1x | 2.8x | 18.3% | 17.3% | 3.4x | 16.6x | 5.7% | 9.9% | 210d |
| FY 2020 | 41.8% | 12.2% | 10.5% | 5.6x | 3.7x | 10.4% | 9.6% | 1.7x | 11.4x | 6.4% | 13.0% | 248d |
| FY 2019 | 42.0% | 7.1% | 5.0% | 5.5x | 3.4x | 4.1% | 4.1% | 2.0x | 20.4x | -3.3% | 15.7% | 300d |
| FY 2018 | 40.6% | 13.5% | 10.4% | 4.7x | 3.2x | 11.2% | 10.9% | 1.1x | 7.2x | 7.0% | 11.7% | 194d |
| FY 2017 | 36.6% | 11.7% | 30.9% | 4.7x | 3.1x | 35.9% | 11.6% | 1.9x | 14.8x | 5.5% | 10.5% | 190d |
| FY 2016 | 37.3% | 6.2% | 4.1% | 5.3x | 2.8x | 5.5% | 6.4% | 1.5x | 19.7x | -2.7% | 12.9% | 263d |
| FY 2015 | 33.7% | 6.9% | 4.9% | 5.6x | 2.8x | 7.7% | 8.1% | 0.9x | 10.3x | 5.5% | 10.8% | 220d |
| FY 2014 | 34.6% | -5.3% | -5.5% | 5.7x | 2.7x | -6.7% | -5.1% | 1.3x | -59.7x | -6.0% | 16.5% | 303d |
| Period | Revenue | Gross profit | R&D | Op income | Net income | EPS | FCF | Capex | Cash + ST inv. | Inventory | Assets | Debt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FY 2025 | -17.6% | -17.1% | +3.3% | -43.4% | -40.2% | -38.2% | -16.8% | +7.3% | -34.5% | +16.6% | +0.9% | -3.1% |
| FY 2024 | -10.0% | -7.5% | +8.9% | -20.7% | -18.4% | -18.0% | -5.6% | +41.0% | +12.9% | -7.9% | +5.2% | -3.3% |
| FY 2023 | +22.9% | +22.3% | +23.7% | +25.2% | +34.5% | +35.7% | -33.5% | -93.4% | +17.1% | +26.4% | +26.5% | -2.6% |
| FY 2022 | +38.9% | +40.3% | +19.8% | +66.8% | +85.6% | +88.4% | +44.9% | -22.5% | +46.5% | +24.3% | +34.6% | -2.1% |
| FY 2021 | +39.6% | +44.2% | +5.8% | +119.4% | +97.4% | +96.0% | +127.2% | -17.3% | +44.9% | +21.1% | +20.6% | -1.6% |
| FY 2020 | +38.4% | +37.8% | +14.7% | +139.8% | +193.4% | +188.5% | +343.6% | +37.9% | +45.5% | +14.8% | +14.0% | -0.8% |
| FY 2019 | -22.5% | -19.8% | +4.0% | -59.6% | -62.9% | -61.5% | -160.5% | -153.8% | -21.4% | +8.8% | -0.1% | +1.7% |
| FY 2018 | +7.8% | +19.6% | +20.4% | +25.3% | -63.9% | -67.2% | -13.8% | +35.3% | +33.4% | +7.0% | +12.3% | +0.1% |
| FY 2017 | +53.8% | +50.9% | +25.2% | +187.8% | +1054.1% | +981.6% | +533.4% | -190.7% | +88.5% | +5.9% | +61.5% | +0.3% |
| FY 2016 | -11.4% | -2.1% | +5.6% | -19.8% | -25.1% | -26.9% | -168.8% | -36.9% | -10.3% | -1.8% | +4.8% | 0.0% |
| FY 2015 | +48.5% | +45.0% | -2.8% | +294.3% | +230.3% | +230.0% | +196.3% | -79.9% | +156.5% | +11.4% | +26.6% | +227.5% |
| FY 2014 | +3.8% | +3.3% | -3.5% | +27.1% | +34.3% | +37.5% | -7.6% | -23.7% | -33.6% | +8.6% | -2.5% | -3.1% |
| Period | Total | Systems | Aftermarket | Ion Implantation Systems Services And Royalties | New Systems Revenue | After Market | Cs I Or Aftermarket | Ion Implantation Systems Services and Royalties | Other Products Systems Services And Royalties | Other Products Systems Services and Royalties |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2025 | $839.0M | $571.0M | $268.0M | -- | -- | -- | -- | -- | -- | -- |
| FY 2024 | $1.02B | $782.6M | $235.3M | -- | -- | -- | -- | -- | -- | -- |
| FY 2023 | $1.13B | $883.6M | $247.0M | -- | -- | -- | -- | -- | -- | -- |
| FY 2022 | $920.0M | $692.1M | $227.9M | -- | -- | -- | -- | -- | -- | -- |
| FY 2021 | $662.4M | $454.6M | $207.8M | -- | -- | -- | -- | -- | -- | -- |
| FY 2020 | $474.6M | -- | -- | -- | $293.6M | -- | $180.9M | -- | -- | -- |
| FY 2019 | $343.0M | -- | -- | -- | $202.6M | $140.4M | -- | -- | -- | -- |
| FY 2018 | $442.6M | -- | -- | -- | $280.4M | $162.2M | -- | -- | -- | -- |
| FY 2017 | $410.6M | -- | -- | $391.1M | -- | -- | -- | -- | $19.5M | -- |
| FY 2016 | $267.0M | -- | -- | $248.9M | -- | -- | -- | -- | $18.1M | -- |
| FY 2015 | $301.5M | -- | -- | $282.6M | -- | -- | -- | -- | $18.9M | -- |
| FY 2013 | $195.6M | -- | -- | -- | -- | -- | -- | $164.0M | -- | $31.6M |
| Period | Total | North America | Asia Pacific | Europe |
|---|---|---|---|---|
| FY 2025 | $839.0M | $137.1M | $610.2M | $91.8M |
| FY 2024 | $1.02B | $144.1M | $781.0M | $92.8M |
| FY 2023 | $1.13B | $174.8M | $811.3M | $144.5M |
| FY 2022 | $920.0M | $634.1M | $247.0M | $39.0M |
| FY 2021 | $662.4M | $519.4M | $106.4M | $36.6M |
| FY 2020 | $474.6M | $351.1M | $94.5M | $29.0M |
| FY 2019 | $343.0M | $256.1M | $58.1M | $28.7M |
| FY 2018 | $442.6M | $342.8M | $70.4M | $29.4M |
| FY 2017 | $410.6M | $313.9M | $69.7M | $26.9M |
| FY 2016 | $267.0M | $191.3M | $50.3M | $25.4M |
| FY 2015 | $301.5M | $226.9M | $50.4M | $24.2M |
| FY 2013 | $195.6M | $117.0M | $50.7M | $27.9M |
2026-08-04EPS est $0.90
GuruFocus · 2026-06-18
Zacks Investment Research · 2026-06-16